BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 30593712)

  • 1. Early detection of esophageal second primary tumors using Lugol chromoendoscopy in patients with head and neck cancer: A systematic review and meta-analysis.
    Bugter O; van de Ven SEM; Hardillo JA; Bruno MJ; Koch AD; Baatenburg de Jong RJ
    Head Neck; 2019 Apr; 41(4):1122-1130. PubMed ID: 30593712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating synchronous esophageal cancer in head and neck cancer patients using Lugol dye chromoendoscopy.
    Laohawiriyakamol S; Sunpaweravong S; Leelamanit V; Pruegsanusak K; Sinkijcharoenchai W
    J Med Assoc Thai; 2014 Nov; 97(11):1164-70. PubMed ID: 25675681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer.
    Muto M; Hironaka S; Nakane M; Boku N; Ohtsu A; Yoshida S
    Gastrointest Endosc; 2002 Oct; 56(4):517-21. PubMed ID: 12297767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Narrow-band imaging vs Lugol chromoendoscopy in screening for esophageal squamous cell neoplasia: a randomized trial.
    Chaber-Ciopinska A; Kiprian D; Wieszczy P; Bielasik A; Bugajski M; Januszewicz W; Jarzabski A; Niemiec M; Mroz A; Kawecki A; Regula J; Kaminski MF
    Pol Arch Intern Med; 2023 Oct; 133(10):. PubMed ID: 36916462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic screening for synchronous esophageal neoplasia among patients with incident head and neck cancer: Prevalence, risk factors, and outcomes.
    Wang YK; Chuang YS; Wu TS; Lee KW; Wu CW; Wang HC; Kuo CT; Lee CH; Kuo WR; Chen CH; Wu DC; Wu IC
    Int J Cancer; 2017 Nov; 141(10):1987-1996. PubMed ID: 28758200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of intensive endoscopic screening for synchronous esophageal neoplasm in patients with head and neck squamous cell carcinoma.
    Kim DH; Gong EJ; Jung HY; Lim H; Ahn JY; Choi KS; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH; Roh JL; Choi SH; Nam SY; Kim SY; Baek S
    Scand J Gastroenterol; 2014 Dec; 49(12):1486-92. PubMed ID: 25372595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routine endoscopic screening for synchronous esophageal neoplasm in patients with head and neck squamous cell carcinoma: a prospective study.
    Gong EJ; Kim DH; Ahn JY; Choi KS; Jung KW; Lee JH; Choi KD; Song HJ; Lee GH; Jung HY; Kim JH; Roh JL; Choi SH; Nam SY; Kim SY
    Dis Esophagus; 2016 Oct; 29(7):752-759. PubMed ID: 26471351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine image-enhanced endoscopic surveillance for metachronous esophageal squamous cell neoplasms in head and neck cancer patients.
    Ye YC; Wang YP; Chang TE; Wu PS; Hsin IF; Chen PH; Tai SK; Chu PY; Hou MC; Lu CL
    Esophagus; 2024 Apr; 21(2):131-140. PubMed ID: 38194013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for dysplasia with Lugol chromoendoscopy in longstanding idiopathic achalasia.
    Ponds FA; Moonen A; Smout AJPM; Rohof WOA; Tack J; van Gool S; Bisschops R; Bredenoord AJ; Boeckxstaens GE
    Am J Gastroenterol; 2018 Jun; 113(6):855-862. PubMed ID: 29748564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Value of Virtual Chromoendoscopy in the Workup of Patients with Head and Neck Squamous Cell Carcinoma.
    Van Lierde C; Gyselinck B; Meulemans J; Bisschops R; Delaere P; Vander Poorten V
    Curr Oncol Rep; 2020 Sep; 22(12):121. PubMed ID: 32989565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lugol chromoendoscopy combined with brush cytology in patients at risk for esophageal squamous cell carcinoma.
    Boller D; Spieler P; Schoenegg R; Neuweiler J; Kradolfer D; Studer R; Grossenbacher R; Zuercher U; Meyenberger C; Borovicka J
    Surg Endosc; 2009 Dec; 23(12):2748-54. PubMed ID: 19444514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for synchronous esophageal second primary tumors in patients with head and neck cancer.
    van de Ven SEM; de Graaf W; Bugter O; Spaander MCW; Nikkessen S; de Jonge PJF; Hardillo JA; Sewnaik A; Monserez DA; Mast H; Keereweer S; Bruno MJ; Baatenburg de Jong RJ; Koch AD
    Dis Esophagus; 2021 Oct; 34(10):. PubMed ID: 34075402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Narrow band imaging versus lugol chromoendoscopy to diagnose squamous cell carcinoma of the esophagus: a systematic review and meta-analysis.
    Morita FH; Bernardo WM; Ide E; Rocha RS; Aquino JC; Minata MK; Yamazaki K; Marques SB; Sakai P; de Moura EG
    BMC Cancer; 2017 Jan; 17(1):54. PubMed ID: 28086818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of esophageal squamous cell carcinomas and lugol-voiding lesions in patients with head and neck squamous cell carcinoma.
    Fukuhara T; Hiyama T; Tanaka S; Oka S; Yoshihara M; Arihiro K; Chayama K
    J Clin Gastroenterol; 2010 Feb; 44(2):e27-33. PubMed ID: 19730116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of simultaneous esophageal lesions in head and neck squamous cell carcinoma: a multivariate analysis.
    Chow TL; Lee DT; Choi CY; Chan TT; Lam SH
    Arch Otolaryngol Head Neck Surg; 2009 Sep; 135(9):882-5. PubMed ID: 19770420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of lugol chromoendoscopy in the oesophagus in patients with head and neck cancer.
    Carvalho R; Areia M; Brito D; Saraiva S; Alves S; Cadime AT
    Rev Esp Enferm Dig; 2013 Feb; 105(2):79-83. PubMed ID: 23659506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-procedure oral administration of pronase improves efficacy of lugol chromoendoscopy in esophageal squamous cell carcinoma screening: a prospective, double-blinded, randomized, controlled trial.
    Zhao X; Guo M; Zhu S; Zhang L; Dong T; Luo H; Yu W; Zhu J; Fan X; Han Y; Liu Z
    Surg Endosc; 2023 Jun; 37(6):4421-4430. PubMed ID: 36781469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Importance of upper digestive endoscopy using lugol dye solution for the diagnosis of superficial esophageal cancer and dysplasia in patients with head and neck neoplasms].
    Tincani AJ; Brandalise N; Andreollo NA; Lopes LR; Montes CG; Altemani A; Martins AS
    Arq Gastroenterol; 2000; 37(2):107-13. PubMed ID: 11144012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of routine esophageal screening in patients with head and neck cancer.
    Su YY; Chen WC; Chuang HC; Guo CS; Lin YT; Luo SD; Fang FM; Chien CY
    JAMA Otolaryngol Head Neck Surg; 2013 Apr; 139(4):350-4. PubMed ID: 23519755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of superficial squamous cell carcinoma developing in the head and neck region in patients with esophageal squamous cell carcinoma.
    Katada C; Muto M; Nakayama M; Tanabe S; Higuchi K; Sasaki T; Azuma M; Ishido K; Katada N; Yamashita K; Nemoto M; Shibata T; Masaki T; Okamoto M; Koizumi W
    Laryngoscope; 2012 Jun; 122(6):1291-6. PubMed ID: 22674532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.